<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-QX6MFWXW</identifier><date>2022</date><creator>Kenda, Sara</creator><relation>documents/doc/Q/URN_NBN_SI_doc-QX6MFWXW_001.pdf</relation><relation>documents/doc/Q/URN_NBN_SI_doc-QX6MFWXW_001.txt</relation><format format_type="issue">5</format><format format_type="volume">73</format><format format_type="type">article</format><format format_type="extent">str. 438</format><identifier identifier_type="COBISSID_HOST">143090435</identifier><identifier identifier_type="ISSN">2536-4316</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-QX6MFWXW</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Bolniki</subject><subject language_type_id="slv">Farmacija</subject><subject language_type_id="slv">Hematologija</subject><subject language_type_id="slv">Posvetovanja</subject><subject language_type_id="slv">Zdravila</subject><title>11. simpozij Sekcije kliničnih farmacevtov</title><title>Hematološki bolnik in zdravila</title></Record>